CO2017005872A2 - Ácido 3-(6-alcoxi-5-clorobenzo[d]isoxazol-3-il)propanoico útil como inhibidores de quinurenina monooxigenasa - Google Patents
Ácido 3-(6-alcoxi-5-clorobenzo[d]isoxazol-3-il)propanoico útil como inhibidores de quinurenina monooxigenasaInfo
- Publication number
- CO2017005872A2 CO2017005872A2 CONC2017/0005872A CO2017005872A CO2017005872A2 CO 2017005872 A2 CO2017005872 A2 CO 2017005872A2 CO 2017005872 A CO2017005872 A CO 2017005872A CO 2017005872 A2 CO2017005872 A2 CO 2017005872A2
- Authority
- CO
- Colombia
- Prior art keywords
- acute
- disease
- severe
- inhibitors
- ethyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
El compuesto de fórmula (I). (Fig. I) en la que: R1 es heteroarilo no sustituido o sustituido con metilo, etilo, halo o =O; y R2 es H, metilo o etilo; y las sales del mismo son inhibidores de KMO y pueden ser útiles en el tratamiento de diversos trastornos, por ejemplo, pancreatitis aguda, enfermedad renal crónica, enfermedad renal aguda, lesión renal aguda, otros estados patológicos asociados con síndrome de respuesta inflamatoria sistémica (SRIS), enfermedad de Huntington, enfermedad de Alzheimer, ataxias espinocerebelosas, enfermedad de Parkinson, complejo SIDA-demencia, infección por VIH, esclerosis lateral amiotrófica (ELA), depresión, esquizofrenia, septicemia, choque cardiovascular, traumatismo grave, lesión pulmonar aguda, síndrome de dificultad respiratoria aguda, colecistitis aguda, quemaduras graves, neumonía, procedimientos quirúrgicos extensos, isquemia intestinal, insuficiencia hepática aguda grave, encefalopatía hepática aguda grave o insuficiencia renal aguda.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB201422727 | 2014-12-19 | ||
| GBGB1508866.9A GB201508866D0 (en) | 2015-05-22 | 2015-05-22 | Compounds |
| PCT/EP2015/080221 WO2016097144A1 (en) | 2014-12-19 | 2015-12-17 | 3-(6-alkoxy-5-chlorobenzo[d]isoxazol-3-yl)propanoic acid useful as kynurenine monooxygenase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO2017005872A2 true CO2017005872A2 (es) | 2017-09-29 |
Family
ID=54850210
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CONC2017/0005872A CO2017005872A2 (es) | 2014-12-19 | 2017-06-14 | Ácido 3-(6-alcoxi-5-clorobenzo[d]isoxazol-3-il)propanoico útil como inhibidores de quinurenina monooxigenasa |
Country Status (26)
| Country | Link |
|---|---|
| US (2) | US9932328B2 (es) |
| EP (1) | EP3233844B1 (es) |
| JP (1) | JP6644790B2 (es) |
| KR (1) | KR102557791B1 (es) |
| CN (1) | CN107108594B (es) |
| AU (1) | AU2015367396C1 (es) |
| BR (1) | BR112017013193B1 (es) |
| CA (1) | CA2969385C (es) |
| CL (1) | CL2017001549A1 (es) |
| CO (1) | CO2017005872A2 (es) |
| CR (1) | CR20170261A (es) |
| DO (1) | DOP2017000141A (es) |
| EA (1) | EA033632B1 (es) |
| ES (1) | ES2737893T3 (es) |
| IL (1) | IL252155B (es) |
| JO (1) | JO3656B1 (es) |
| MX (1) | MX2017008069A (es) |
| NZ (1) | NZ732002A (es) |
| PE (1) | PE20171259A1 (es) |
| PH (1) | PH12017500993A1 (es) |
| SG (1) | SG11201703807VA (es) |
| TW (1) | TWI698433B (es) |
| UA (1) | UA120381C2 (es) |
| UY (1) | UY36451A (es) |
| WO (1) | WO2016097144A1 (es) |
| ZA (1) | ZA201702918B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ732002A (en) * | 2014-12-19 | 2023-07-28 | Univ Court Univ Of Edinburgh | 3-(6-alkoxy-5-chlorobenzo[d]isoxazol-3-yl)propanoic acid useful as kynurenine monooxygenase inhibitors |
| KR101684053B1 (ko) * | 2015-01-20 | 2016-12-08 | 씨제이헬스케어 주식회사 | 벤즈이미다졸 유도체의 신규 결정형 및 이의 제조방법 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7622495B2 (en) * | 2006-10-03 | 2009-11-24 | Neurim Pharmaceuticals (1991) Ltd. | Substituted aryl-indole compounds and their kynurenine/kynuramine-like metabolites as therapeutic agents |
| WO2008142134A1 (en) | 2007-05-24 | 2008-11-27 | Neurosearch A/S | Benzisoxazole derivatives as potassium channel modulators for the treatment of e.g. respiratory diseases, epilepsy and convulsions |
| WO2010011302A1 (en) * | 2008-07-22 | 2010-01-28 | Chdi, Inc. | Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
| US8691824B2 (en) * | 2008-08-04 | 2014-04-08 | Chdi Foundation, Inc. | Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof |
| EP2528441A4 (en) * | 2010-01-25 | 2013-07-10 | Chdi Foundation Inc | CERTAIN KYNURENIN-3-MONOOXYGENASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF |
| CN103827095A (zh) * | 2011-08-30 | 2014-05-28 | Chdi基金会股份有限公司 | 犬尿氨酸-3-单加氧酶抑制剂、其药物组合物及其使用方法 |
| GB201322512D0 (en) * | 2013-12-19 | 2014-02-05 | Glaxosmithkline Ip Dev Ltd | Novel compounds |
| NZ732002A (en) * | 2014-12-19 | 2023-07-28 | Univ Court Univ Of Edinburgh | 3-(6-alkoxy-5-chlorobenzo[d]isoxazol-3-yl)propanoic acid useful as kynurenine monooxygenase inhibitors |
-
2015
- 2015-12-17 NZ NZ732002A patent/NZ732002A/en unknown
- 2015-12-17 TW TW104142406A patent/TWI698433B/zh active
- 2015-12-17 AU AU2015367396A patent/AU2015367396C1/en active Active
- 2015-12-17 UA UAA201707042A patent/UA120381C2/uk unknown
- 2015-12-17 PE PE2017001084A patent/PE20171259A1/es unknown
- 2015-12-17 SG SG11201703807VA patent/SG11201703807VA/en unknown
- 2015-12-17 JO JOP/2015/0324A patent/JO3656B1/ar active
- 2015-12-17 KR KR1020177016276A patent/KR102557791B1/ko active IP Right Grant
- 2015-12-17 MX MX2017008069A patent/MX2017008069A/es active IP Right Grant
- 2015-12-17 CR CR20170261A patent/CR20170261A/es unknown
- 2015-12-17 EP EP15810681.5A patent/EP3233844B1/en active Active
- 2015-12-17 WO PCT/EP2015/080221 patent/WO2016097144A1/en active Application Filing
- 2015-12-17 CN CN201580068887.0A patent/CN107108594B/zh active Active
- 2015-12-17 BR BR112017013193-5A patent/BR112017013193B1/pt active IP Right Grant
- 2015-12-17 JP JP2017532625A patent/JP6644790B2/ja active Active
- 2015-12-17 CA CA2969385A patent/CA2969385C/en active Active
- 2015-12-17 EA EA201791402A patent/EA033632B1/ru not_active IP Right Cessation
- 2015-12-17 US US15/537,805 patent/US9932328B2/en active Active
- 2015-12-17 UY UY0001036451A patent/UY36451A/es active IP Right Grant
- 2015-12-17 ES ES15810681T patent/ES2737893T3/es active Active
-
2017
- 2017-04-26 ZA ZA2017/02918A patent/ZA201702918B/en unknown
- 2017-05-08 IL IL252155A patent/IL252155B/en active IP Right Grant
- 2017-05-29 PH PH12017500993A patent/PH12017500993A1/en unknown
- 2017-06-14 DO DO2017000141A patent/DOP2017000141A/es unknown
- 2017-06-14 CO CONC2017/0005872A patent/CO2017005872A2/es unknown
- 2017-06-15 CL CL2017001549A patent/CL2017001549A1/es unknown
-
2018
- 2018-02-20 US US15/900,043 patent/US10273232B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CU20160095A7 (es) | Compuestos derivados de 4-(imidazol-1-il)-n-(2-(1,2,4-triazol-3-il)-1,3-tiazol-4-il)picolinamida con actividad inhibitoria de la quinasa reguladora de la señal de apoptosis | |
| PH12016501633A1 (en) | Condensed [1,4]diazepine compounds as autotaxin (atx) and lysophosphatidic acid (lpa) production inhibitors | |
| MX2017006302A (es) | Derivados de adenina que son utiles en el tratamiento de enfermedades alergicas u otras afecciones inflamatorias. | |
| BR112016015717A8 (pt) | macrociclos com grupos p2' heterocíclicos como inibidores do fator xia | |
| EA201790715A1 (ru) | Новые соединения | |
| TWD180330S (zh) | 清掃機器人之部分（三） | |
| GT201500334A (es) | Compuestos de 3,4- dihidroisoquinolin-2-(1h)-ilo | |
| NZ718622A (en) | Multisubstituted aromatic compounds as inhibitors of thrombin | |
| CA3010327A1 (en) | Aryl substituted pyrimidines for use in influenza virus infection | |
| EA201891278A1 (ru) | Гетероциклические индолы для применения при инфекции, вызванной вирусом гриппа | |
| MX352760B (es) | Metodos para tratar infecciones intrapulmonares. | |
| MA38645A1 (fr) | Nouveaux inhibiteurs de cyp17/antiandrogènes | |
| BR112017006425A2 (pt) | derivado de isoxazol como inibidor de isocitrato desidrogenase 1 mutante | |
| ZA202100352B (en) | Novel 3, 5-disubstituted pyridine and 3, 5-disubstituted pyridazine derivatives and pharmaceutical use of same | |
| IN2014CN00572A (es) | ||
| CO2017005872A2 (es) | Ácido 3-(6-alcoxi-5-clorobenzo[d]isoxazol-3-il)propanoico útil como inhibidores de quinurenina monooxigenasa | |
| FR3021315B1 (fr) | Compose 1,3-dipolaire portant une fonction ester d'acide carboxylique et composition de caoutchouc le contenant | |
| EA201492256A1 (ru) | Пролекарства 5-(5-фенил-4-(пиридин-2-илметиламино)хиназолин-2-ил)пиридин-3-сульфонамида на основе фосфорамидной кислоты | |
| BR112017025008A2 (pt) | Derivados de ácido 3-(5-cloro-2-oxo-2,3-di-hidro-1,3- benzotiazol-3-il) propanóico e seu uso como inibidores de kmo | |
| WO2014057415A3 (en) | Inhibitors of dna gyrase for the treatment of bacterial infections | |
| BR112017025052A2 (pt) | ?derivados de ácido 3-(6-cloro-3-oxo-3,4-di-hidro- (2h)-1,4- benzotiazol -4-il) propanóico e seu uso como inibidores de kmo.? | |
| CN302103848S (zh) | 橱柜面板 | |
| TWD175560S (zh) | 眼鏡鏡腳(二) | |
| CN302103847S (zh) | 橱柜柜体（2） | |
| CN302327074S (zh) | 吊锭架 |